New Innovations in Food Allergy Testing and Patient Care
Wednesday, June 16th, 4:30-6:00pm ET
Scientists estimate that food allergies affect at least 32 million Americans, including approximately 6 million children. The Centers for Disease Control and Prevention (CDC) report that food allergies in children have increased by 50 percent between 1997 and 2011, with an even higher increase for peanut allergies. Recent years have seen significant advances in understanding of responses to food allergens such as the development of dose-response models that hold promise for developing more informative labels on food packaging. This session will highlight new research and innovations to enhance food allergen risk assessment and management. These include novel, safe methods for accurate diagnosis of food allergies and severity, and new initiatives for optimizing large-scale research trials and enhancing patient care.
The Current US Food Allergen Regulatory Landscape
Stefano Luccioli, MD
Senior Medical Advisor, Office of Food Additive Safety, FDA CFSAN
The FARE Clinical Network: Advancing New Treatments and Preventive Therapies for Food Allergy Patients
Bruce Roberts, PhD
Chief Research Strategy and Innovation Officer, Food Allergy Research & Education (FARE)
Opening the Allergy Black Box: The Path to Risk-Free Challenge Testing
Paul Kearney, PhD
Chief Scientific Officer, AllerGenis
Jason Hlywka, PhD
The Kraft Heinz Company
Continuing Education Hours: IAFNS is an approved Continuing Professional Education (CPE) provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.5 Continuing Professional Education units (CPEUs) for completion of this live session.